MTOR and non-Hodgkin lymphoma: In this context, we analyzed RNA seq data from n = 624 NHL tumors consisting of genetic mutations (n = 361) with unaltered (n = 263) TP53, MYC, BCL2, mTOR, MYD88, PIM2, and CREBP and identified differentially expressed metabolic genes (Figure 7A).